These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29893459)

  • 41. Cooperativity of copper and molybdenum centers in polyoxometalate-based electrocatalysts: cyclic voltammetry, EQCM, and AFM characterization.
    Keita B; Abdeljalil E; Nadjo L; Contant R; Belghiche R
    Langmuir; 2006 Dec; 22(25):10416-25. PubMed ID: 17129010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of polyoxometalates as inhibitors of basic fibroblast growth factor.
    Pu F; Wang E; Jiang H; Ren J
    Mol Biosyst; 2013 Jan; 9(1):113-20. PubMed ID: 23123725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitumor Metallodrugs that Target Proteins.
    Sullivan MP; Holtkamp HU; Hartinger CG
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functionalized polyoxometalates with covalently linked bisphosphonate, N-donor or carboxylate ligands: from electrocatalytic to optical properties.
    Dolbecq A; Mialane P; Sécheresse F; Keita B; Nadjo L
    Chem Commun (Camb); 2012 Aug; 48(67):8299-316. PubMed ID: 22763503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chitosan nanogels as nanocarriers of polyoxometalates for breast cancer therapies.
    Pérez-Álvarez L; Ruiz-Rubio L; Artetxe B; Vivanco MD; Gutiérrez-Zorrilla JM; Vilas-Vilela JL
    Carbohydr Polym; 2019 Jun; 213():159-167. PubMed ID: 30879655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategic design and refinement of Lewis acid-base catalysis by rare-earth-metal-containing polyoxometalates.
    Suzuki K; Sugawa M; Kikukawa Y; Kamata K; Yamaguchi K; Mizuno N
    Inorg Chem; 2012 Jun; 51(12):6953-61. PubMed ID: 22672013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. All-Inorganic Polyoxometalates Act as Superchaotropic Membrane Carriers.
    Barba-Bon A; Gumerova NI; Tanuhadi E; Ashjari M; Chen Y; Rompel A; Nau WM
    Adv Mater; 2024 Jan; 36(1):e2309219. PubMed ID: 37943506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?
    Levina A; Lay PA
    Chem Asian J; 2017 Jul; 12(14):1692-1699. PubMed ID: 28401668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo.
    Dong Z; Tan R; Cao J; Yang Y; Kong C; Du J; Zhu S; Zhang Y; Lu J; Huang B; Liu S
    Eur J Med Chem; 2011 Jun; 46(6):2477-84. PubMed ID: 21481498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of weak interactions in the crystal packing of inorganic metalorganic hybrids based on Keggin polyoxometalates and dinuclear copper(II)-acetate complexes.
    Reinoso S; Vitoria P; Felices LS; Lezama L; Gutiérrez-Zorrilla JM
    Inorg Chem; 2006 Jan; 45(1):108-18. PubMed ID: 16390046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compounds of Mo, V and W in biochemistry and their biomedical activity.
    Jelikić-Stankov M; Uskoković-Marković S; Holclajtner-Antunović I; Todorović M; Djurdjević P
    J Trace Elem Med Biol; 2007; 21(1):8-16. PubMed ID: 17317520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effective inhibitory activity against MCF-7, A549 and HepG2 cancer cells by a phosphomolybdate based hybrid solid.
    Joshi A; Gupta R; Singh B; Sharma D; Singh M
    Dalton Trans; 2020 Jun; 49(21):7069-7077. PubMed ID: 32400784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, immunomodulation and cytotoxic effects of vanadium (IV) complexes.
    Ashiq U; Jamal RA; Mesaik MA; Mahroof-Tahir M; Shahid S; Khan KM
    Med Chem; 2014 May; 10(3):287-99. PubMed ID: 23876231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, characterisation and cytotoxicity of polyoxometalate/carboxymethyl chitosan nanocomposites.
    Geisberger G; Paulus S; Carraro M; Bonchio M; Patzke GR
    Chemistry; 2011 Apr; 17(16):4619-25. PubMed ID: 21322072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beyond Charge Balance: Counter-Cations in Polyoxometalate Chemistry.
    Misra A; Kozma K; Streb C; Nyman M
    Angew Chem Int Ed Engl; 2020 Jan; 59(2):596-612. PubMed ID: 31260159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aliphatic organoimido derivatives of polyoxometalates containing a bioactive ligand.
    She S; Bian S; Hao J; Zhang J; Zhang J; Wei Y
    Chemistry; 2014 Dec; 20(51):16987-94. PubMed ID: 25346326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Super-reduced polyoxometalates: excellent molecular cluster battery components and semipermeable molecular capacitors.
    Nishimoto Y; Yokogawa D; Yoshikawa H; Awaga K; Irle S
    J Am Chem Soc; 2014 Jun; 136(25):9042-52. PubMed ID: 24885348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell-Active Inorganics.
    Laws K; Suntharalingam K
    Chembiochem; 2018 Nov; 19(21):2246-2253. PubMed ID: 30109911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanoscale polyoxometalate-based inorganic/organic hybrids.
    Song YF; Long DL; Ritchie C; Cronin L
    Chem Rec; 2011 Jun; 11(3):158-71. PubMed ID: 21594969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ctDNA binding affinity and in vitro antitumor activity of three Keggin type polyoxotungestates.
    Dianat S; Bordbar AK; Tangestaninejad S; Yadollahi B; Zarkesh-Esfahani SH; Habibi P
    J Photochem Photobiol B; 2013 Jul; 124():27-33. PubMed ID: 23648797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.